Helex
About:
Enabling Safer Gene Editing
Website: http://www.helex.bio
Top Investors: IndieBio, SOSV
Description:
Helex uses its own genomics data, bioinformatics, and intelligent data-driven platform to create, verify, and distribute therapy-specific gRNAs. Founded in 2021 and is based in New York.
Total Funding Amount:
$1.13M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New York, New York, United States
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-04-26
IPO Status:
Private
Industries:
© 2025 bioDAO.ai